The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis

Helei Hou,* Dantong Sun,* Kewei Liu, Man Jiang, Dong Liu, Jingjuan Zhu, Na Zhou, Jing Cong, Xiaochun ZhangDepartment of Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People’s Republic of China*These authors contributed equally to this workBackgro...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hou H, Sun D, Liu K, Jiang M, Liu D, Zhu J, Zhou N, Cong J, Zhang X
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2019-05-01
coleção:	Cancer Management and Research
Assuntos:	ALK inhibitors adverse events serious adverse events lung toxicity
Acesso em linha:	https://www.dovepress.com/the-safety-and-serious-adverse-events-of-approved-alk-inhibitors-in-ma-peer-reviewed-article-CMAR
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!